Search

Your search keyword '"Fungal Proteins drug effects"' showing total 176 results

Search Constraints

Start Over You searched for: Descriptor "Fungal Proteins drug effects" Remove constraint Descriptor: "Fungal Proteins drug effects"
176 results on '"Fungal Proteins drug effects"'

Search Results

1. Structure and inhibition of Cryptococcus neoformans sterylglucosidase to develop antifungal agents.

2. Fungal cell wall: An underexploited target for antifungal therapies.

3. Novel Carboline Fungal Histone Deacetylase (HDAC) Inhibitors for Combinational Treatment of Azole-Resistant Candidiasis.

4. Diverse effects of aqueous polar co-solvents on Candida antarctica lipase B.

5. Impact of Cigarette Smoke Condensate on Adhesion-Related Traits and Hemolysin Production of Oral Candida dubliniensis Isolates.

6. Vanillin confers antifungal drug synergism in Candida albicans by impeding CaCdr2p driven efflux.

7. Developing a tetO/TetR system in Neurospora crassa.

8. Subunits of the vacuolar H+-ATPase complex, Vma4 and Vma10, are essential for virulence and represent potential drug targets in Candida albicans.

9. Acquisition of FKS2 mutation after echinocandin treatment of infective endocarditis by Candida glabrata.

10. Molecular targets of biofabricated silver nanoparticles in Candida albicans.

11. Structural basis for species-selective targeting of Hsp90 in a pathogenic fungus.

12. Potential targets for the development of new antifungal drugs.

13. Catabolism of phenylacetic acid in Penicillium rubens. Proteome-wide analysis in response to the benzylpenicillin side chain precursor.

14. Omics for understanding the tolerant mechanism of Trichoderma asperellum TJ01 to organophosphorus pesticide dichlorvos.

15. A halotolerant bifunctional β-xylosidase/α-l-arabinofuranosidase from Colletotrichum graminicola: Purification and biochemical characterization.

16. Emergence of Aspergillus fumigatus azole resistance in azole-naïve patients with chronic obstructive pulmonary disease and their homes.

17. Proteoform Suite: Software for Constructing, Quantifying, and Visualizing Proteoform Families.

18. Candida albicans Impairments Induced by Peppermint and Clove Oils at Sub-Inhibitory Concentrations.

19. A pre-therapeutic coating for medical devices that prevents the attachment of Candida albicans.

20. New azole derivatives showing antimicrobial effects and their mechanism of antifungal activity by molecular modeling studies.

21. Casein phosphopeptides and CaCl 2 increase penicillin production and cause an increment in microbody/peroxisome proteins in Penicillium chrysogenum.

22. Azole susceptibility in clinical and environmental isolates of Aspergillus fumigatus from eastern Hokkaido, Japan.

23. β1 Tubulin Rather Than β2 Tubulin Is the Preferred Binding Target for Carbendazim in Fusarium graminearum.

24. Biodegradation of zearalenone by Saccharomyces cerevisiae: Possible involvement of ZEN responsive proteins of the yeast.

25. Comprehensive quantification of N-glycoproteome in Fusarium graminearum reveals intensive glycosylation changes against fungicide.

26. Proteomic analysis of an environmental isolate of Rhodotorula mucilaginosa after arsenic and cadmium challenge: Identification of a protein expression signature for heavy metal exposure.

27. Proteomic response of the phytopathogen Phyllosticta citricarpa to antimicrobial volatile organic compounds from Saccharomyces cerevisiae.

28. Clinical perspectives on echinocandin resistance among Candida species.

29. The CYP51F1 Gene of Leptographium qinlingensis: Sequence Characteristic, Phylogeny and Transcript Levels.

30. Enhancement of extracellular cellobiase activity by reducing agents in the filamentous fungus Termitomyces clypeatus.

31. Echinocandin resistance: an emerging clinical problem?

32. Pneumocystis jirovecii Rtt109, a novel drug target for Pneumocystis pneumonia in immunosuppressed humans.

33. Dodoviscin a inhibits melanogenesis in mouse b16-f10 melanoma cells.

34. Pseudomonas aeruginosa lipopolysaccharide inhibits Candida albicans hyphae formation and alters gene expression during biofilm development.

35. Susceptibility to caspofungin and fluconazole and Als1/Als3 gene expression in biofilm and dispersal cells of Candida albicans.

36. [Effect of elevated O3 on the arbuscular mycorrhizal (AM) structure and glomalin production in two genotypes of snap bean].

37. A novel functional assay for fungal histidine kinases group III reveals the role of HAMP domains for fungicide sensitivity.

38. Genotypic, phenotypic, and proteomic characterization of Candida glabrata during sequential fluconazole exposure.

39. A novel polyamide SL-A92 as a potential fungal resistance blocker: synthesis and bioactivities in Candida albicans.

40. The intra- and extracellular proteome of Aspergillus niger growing on defined medium with xylose or maltose as carbon substrate.

41. The antifungal protein PAF interferes with PKC/MPK and cAMP/PKA signalling of Aspergillus nidulans.

42. Inhibitory effect of CuSO₄ on α-glucosidase activity in ddY mice.

43. Nutrient sensing G protein-coupled receptors: interesting targets for antifungals?

44. Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure.

45. Inference of protein complex activities from chemical-genetic profile and its applications: predicting drug-target pathways.

46. Intracellular pH homeostasis plays a role in the tolerance of Debaryomyces hansenii and Candida zeylanoides to acidified nitrite.

47. Exploring the inhibitor binding pocket of respiratory complex I.

48. Tetracycline effects on Candida albicans virulence factors.

49. Farnesol and dodecanol effects on the Candida albicans Ras1-cAMP signalling pathway and the regulation of morphogenesis.

50. Preprotein transport machineries of yeast mitochondrial outer membrane are not required for Bax-induced release of intermembrane space proteins.

Catalog

Books, media, physical & digital resources